as on November 7, 2025 at 2:29 am IST
Day's Low
Day's High
1.61%
Downside
5.46%
Upside
52 Week's Low
52 Week's High
54.96%
Downside
24.55%
Upside
Check Regenxbio Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$586.5M
EPS (TTM)
-2.2778
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-2.46
Industry PE ratio
-0.8126129032258065
PEG Ratio
0.26
EBITDA
-148.8M
Revenue (TTM)
155.8M
Profit Margin
-112.70%
Return On Equity TTM
-62.49%
Track how Regenxbio Inc P/E has moved over time to understand its valuation trends.
Regenxbio Inc in the last 5 years
Lowest (-14.61x)
March 31, 2021
Today (-2.46x)
November 7, 2025
Industry (-0.81x)
November 7, 2025
Highest (19.14x)
September 30, 2022
Today’s Price to Earnings Ratio: -2.46x
Compare market cap, revenue, PE, and other key metrics of Regenxbio Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $586.5M | -62.78% | -2.46 | -112.70% | |
| BUY | $39.6B | 470.1% | -16.34 | -264.83% | |
| BUY | $57.4B | 236.95% | 1448.53 | 1.36% | |
| BUY | $105.8B | 88.96% | 29.32 | 31.35% | |
| BUY | $67.7B | 11.91% | 15.43 | 32.13% |
The Regenxbio Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Regenxbio Inc investment value today
Current value as on today
₹1,05,017
Returns
₹5,017
(+5.02%)
Returns from Regenxbio Inc Stock
Dollar Returns*
₹5,107 (+5.11%)
Based on 18 analysts
88.89%
Buy
11.11%
Hold
0.00%
Sell
Based on 18 analysts, 88.89% of analysts recommend a 'BUY' rating for Regenxbio Inc. Average target price of $29.27
Get share price movements and forecasts by analysts on Regenxbio Inc.
What analysts predicted
61.8%UPSIDE
Target Price
$29.27
Current Price
$11.18
Analyzed by
18 Analysts
Target
$29.27
Regenxbio Inc target price $29.27, a slight upside of 61.8% compared to current price of $11.18. According to 18 analysts rating.
Search interest for Regenxbio Inc Stock has increased by 229% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:229% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 3 months, RGNX stock has moved up by 41.4%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 159.0% return, outperforming this stock by 159.2%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 921.9% return, outperforming this stock by 968.3%
Profit Down
![]()
Netprofit is down for the last 2 quarters, 6.08M → -70.87M (in $), with an average decrease of 1265.1% per quarter
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 89.01M → 21.35M (in $), with an average decrease of 76.0% per quarter
| Organisation | Regenxbio Inc |
| Headquarters | 9804 Medical Center Drive, Rockville, MD, United States, 20850 |
| Industry | Health Technology |
| CEO | Mr. Curran M. Simpson M.S. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Curran M. Simpson M.S. | President, CEO & Director |
Mr. Mitchell Chan M.B.A. | Executive VP & CFO |
Mr. Patrick J. Christmas II, J.D. | Executive VP & Chief Strategy and Legal Officer |
Mr. Craig Malzahn | Executive VP of Product Development & CTO |
Ms. Shiva G. Fritsch | Chief Communications & People Officer |
Dr. Ram Palanki Pharm.D. | Executive VP & Chief Commercial Officer |
Dr. Jahannaz Dastgir D.O. | Clinical Development Lead |
Dr. Olivier Danos Ph.D. | Executive VP & Chief Scientific Officer |
Dr. Stephen Pakola M.D. | Executive VP & Chief Medical Officer |
Ms. Sarah Thomas | Senior Vice President of Quality |
Regenxbio Inc share price today is $11.18 as on at the close of the market. Regenxbio Inc share today touched a day high of $11.79 and a low of $11.
Regenxbio Inc share touched a 52 week high of $13.93 on and a 52 week low of $5.04 on . Regenxbio Inc stock price today i.e. is closed at $11.18,which is 19.71% down from its 52 week high and 122.05% up from its 52 week low.
Regenxbio Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Regenxbio Inc (RGNX) shares with as little as ₹88.626 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.26 in Regenxbio Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Regenxbio Inc share’s latest price of $11.18 as on November 7, 2025 at 2:29 am IST, you will get 0.8945 shares of Regenxbio Inc. Learn more about
fractional shares .
Regenxbio Inc stock has given -62.78% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?